发明授权
- 专利标题: Tumor-targeted optical contrast agents
- 专利标题(中): 肿瘤靶向光学造影剂
-
申请号: US10654033申请日: 2003-09-03
-
公开(公告)号: US07198778B2公开(公告)日: 2007-04-03
- 发明人: Samuel I. Achilefu , Raghavan Rajagopalan , Richard B. Dorshow , Joseph E. Bugaj , Muthunadar P. Periasamy
- 申请人: Samuel I. Achilefu , Raghavan Rajagopalan , Richard B. Dorshow , Joseph E. Bugaj , Muthunadar P. Periasamy
- 申请人地址: US MO St. Louis
- 专利权人: Mallinckrodt Inc.
- 当前专利权人: Mallinckrodt Inc.
- 当前专利权人地址: US MO St. Louis
- 代理机构: Wood, Herron & Evans, L.L.P.
- 主分类号: A61B10/00
- IPC分类号: A61B10/00 ; A61B8/00
摘要:
Cyanine dye bioconjugates useful for diagnostic imaging and therapy are disclosed. The conjugates include several cyanine dyes with a variety of bis- and tetrakis (carboxylic acid) homologs. The compounds may be conjugated to bioactive peptides, carbohydrates, hormones, drugs, or other bioactive agents. The small size of the compounds allows more favorable delivery to tumor cells as compared to larger molecular weight imaging agents. The various dyes are useful over the range of 350 to 1300 nm, the exact range being dependent upon the particular dye. The use of dimethylsulfoxide helps to maintain the fluorescence of the compounds. The inventive compounds are useful for diagnostic imaging and therapy, in endoscopic applications for the detection of tumors and other abnormalities, for localized therapy, for photoacoustic tumor imaging, detection and therapy, and for sonofluoresence tumor imaging, detection and therapy.
公开/授权文献
- US20040141920A1 Tumor-targeted optical contrast agents 公开/授权日:2004-07-22
信息查询